乐心医疗：电子血压计医疗器械注册证延续事项已通过审批

Group 1 - Core viewpoint: 乐心医疗 has received approval for the renewal of its electronic blood pressure monitor medical device registration from the Guangdong Provincial Drug Administration [1] - Revenue composition for 乐心医疗 in the first half of 2025: home medical products account for 66.29%, electronic health scales for 24.17%, others for 7.55%, and wearable fitness trackers for 1.99% [1] - Current market capitalization of 乐心医疗 is 3 billion yuan [1]